A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer.
Cell Rep. 2022 Feb 22;38(8):110417. doi: 10.1016/j.celrep.2022.110417.
Cell Rep. 2022.
PMID: 35196489
Free PMC article.